Phong Phu Pharmaceutical JSC (HNX: PPP)

Market Cap	146.08B
Revenue (ttm)	137.55B
Net Income (ttm)	17.36B
Shares Out	8.80M
EPS (ttm)	1,766.00
PE Ratio	9.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,101
Average Volume	5,472
Open	16,500
Previous Close	16,700
Day's Range	16,000 - 16,600
52-Week Range	14,800 - 20,600
Beta	0.07
RSI	43.06
Earnings Date	Jan 23, 2025

About HNX: PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2024, PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 17.36 billion, a decrease of -13.72%.